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Abstract—The purpose of this study was to determine whether sinoaortic deafferentation (SAD) alters the severity of
hypertension or sympathoadrenal contribution to mean blood pressure (MAP) during renal wrap hypertension. Male
Sprague-Dawley rats were implanted with radiotelemetry transmitters for 24-hour recording of MAP and heart rate. All
rats underwent either SAD or sham SAD (Intact) surgery and were allowed to recover for 10 to 14 days. The rats were
then assigned to a normotensive (Sham) group or a hypertensive (Wrap) group in which 1-kidney figure-8 renal wrap
was performed. SAD increased the acute MAP response to renal wrap (Intact-Sham5561 mm Hg, IntactWrap54563 mm Hg, SAD-Sham5363 mm Hg, SAD-Wrap55864 mm Hg) and increased the lability of MAP (SD
of MAP; Intact-Sham53.860.2, Intact-Wrap54.260.3, SAD-Sham59.661.4, SAD-Wrap59.761.4). MAP was not
different between SAD and Intact rats during 4 weeks after renal wrap or sham surgery; however, induction of
hypertension produced additional MAP variability that was independent of SAD (Intact-Sham54.660.4, IntactWrap56.260.6, SAD-Sham56.360.5, SAD-Wrap510.861.5). In a separate group of rats, the sympathoadrenal
contribution to MAP was assessed by the depressor response to ganglionic blockade and plasma norepinephrine at rest
and after neuronal uptake inhibition with desipramine. The depressor response to ganglionic blockade was significantly
increased by renal wrap and by SAD (Intact-Sham524962 mm Hg, Intact-Wrap527364 mm Hg, SADSham527765 mm Hg, SAD-Wrap529666 mm Hg). In the 3 groups with enhanced ganglionic blockade responses,
desipramine caused a significant increase in plasma norepinephrine. These results indicate that SAD does not alter the
development of renal wrap hypertension but does increase the sympathoadrenal contribution to MAP in both
normotensive and hypertensive animals. (Hypertension. 1999;33[part II]:476-481.)
Key Words: sympathetic activity n sinoaortic denervation n barodenervation n radiotelemetry

T

he arterial baroreceptor reflex buffers acute changes in
blood pressure via feedback control of sympathetic and
parasympathetic nerve activity. This reflex maintains relatively constant arterial pressure by altering vascular conductance and heart rate (HR). However, in chronic hypertension,
the moment-to-moment blood pressure regulation resets to a
higher level of pressure.1 Because of the resetting process
during the development of hypertension, this reflex does not
effectively counteract mechanisms that permanently elevate
mean arterial pressure (MAP). In addition to baroreflex
resetting, the sensitivity of the reflex has been shown to be
reduced in the hypertensive state.2 Thus it has been suggested
that impaired baroreflex function may play a permissive role
in the enhancement of sympathoadrenal activity that is a
hallmark of many forms of experimental hypertension.3,4
The goal of the present study was to determine whether
altered baroreflex function contributes to the onset or maintenance of renal wrap hypertension, or both. After the acute
sympathoexcitatory effects of sinoaortic deafferentation
(SAD), the absence of baroreceptor input prevents baroreflex-

mediated inhibition of sympathoadrenal activity and severely
suppresses baroreflex sensitivity. Consequently, it was proposed that if the baroreflex actively limited the sympathetic
nervous system in hypertension, there would be a greater
neurogenic component contributing to a higher arterial pressure after SAD. Because of this, sinoaortic deafferentation
was used in this study to determine the role of the baroreflex
in determining sympathoadrenal activity and, in turn, arterial
pressure after 1-kidney figure-8 renal wrap hypertension. It
was hypothesized that animals without an intact baroreflex
would have augmented sympathoadrenal activity, resulting in
more severe hypertension.

Methods
Subjects
Male Sprague-Dawley rats (Charles River; n572) were kept under a
constant 14-hour light/10-hour dark cycle and provided rat chow
(Teklad) and tap water ad libitum throughout the duration of the
study. Animals were age matched and assigned to study 1 for
long-term measurement of arterial pressure with radiotelemetry or
study 2 for assessment of sympathoadrenal contribution to MAP. All
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Efficacy of SAD
Parameter Tested

Intact-Sham

Intact-Wrap

SAD-Sham

SAD-Wrap
3363*

MAP response to SAD, mm Hg

361

161

3164*

Water intake after SAD, ml/d

3565

3762

662*

562*

SD of MAP

3.860.2

4.260.3

9.661.4*

9.761.4*

DHR/DMAP-PE

22.460.4

21.960.2

20.460.1*

20.460.1*

DHR/DMAP-NP

22.460.2

22.060.2

20.460.2*

20.460.2*

Efficacy of SAD was assessed with the use of four criteria: (1) the increase in MAP on the day after
SAD, (2) inhibition of water intake on the day after SAD, (3) lability of MAP (using SD of MAP as an
index), and (4) baroreflex-mediated alterations in HR (DHR) in response to changes in MAP (DMAP)
induced by phenylephrine (PE) and nitroprusside (NP). Baroreflex control of HR was assessed 39 to
43 days after SAD surgery.
*P,0.05 vs respective intact group.
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experimental protocols were approved by the University’s Institutional Animal Care and Use Committee. Animals were treated in
accordance with the American Physiological Society’s Guiding
Principles for the Use of Animals in Research and Testing. The
University of Texas Health Science Center at San Antonio is an
AAALAC International accredited institution.

Surgical Interventions
Study 1
Under gaseous anesthesia (Metofane; Mallinckrodt Veterinary), rats
were surgically implanted with a TA11PA-C40 radiotelemetry transmitter (Data Sciences). From 7 to 10 days after implantation surgery
and after the measurement of control arterial pressure and HR,
animals were assigned to either undergo SAD or sham (Intact)
surgery. For SAD, rats were anesthetized (ketamine/xylazine/
acepromazine IM), and SAD was performed according to the
methods of Schreihofer and Sved.5 A chronic indwelling catheter
was inserted into the femoral vein for measurement of cardiac
baroreflex function to test the efficacy of SAD. From 10 to 14 days
later, rats were returned to the laboratory for induction of hypertension by 1-kidney figure-8 renal wrap, or Sham renal wrap (unilateral
nephrectomy alone). For these procedures, the rat was anesthetized
(Metofane), and the kidneys were approached through a flank
incision. Renal wrap was performed according to the methods of
Grollman et al.6 MAP and HR measurements were continuously
made throughout the periods after SAD and renal wrap until 4 weeks
after the wrap.

Study 2
A separate group of age-matched rats were prepared in a manner
similar to those used in study 1. However, radiotelemetry transmitters were not implanted. Instead, at the end of the third week after
renal wrap, the rats were anesthetized (Metofane) and implanted with
a chronic indwelling arterial catheter for measurement of MAP and
collection of blood samples, and a venous catheter was used for
injection of drugs.

Experimental Protocols and Data Collection
Study 1
Animals prepared with radiotelemetry transmitters were housed in
individual wire mesh cages containing an RLA-3000 radiotelemetry
receiver (Data Sciences International). Every 10 minutes, a 20second measurement of MAP and HR was acquired, and the data
were averaged to obtain a single hourly value for each parameter
(DataQuest A.R.T.; DSI International). Body weight and fluid intake
were measured daily. To test for complete SAD, bolus injections of
phenylephrine hydrochloride (1 and 2 mg/kg; Sigma) and sodium
nitroprusside (2 and 4 mg/kg; Sigma) were administered. During
baroreflex control of HR testing, MAP and HR were measured
continuously via telemetry at a sampling rate of 0.5 Hz. The peak
responses were expressed as changes from the control period, and a

ratio of DHR/DMAP was used to determine whether SAD surgery
was effective.

Study 2
Catheterized animals were housed individually in Plexiglas cages
with wire mesh bottoms. The day before data collection, they were
brought to the laboratory for 4 to 5 hours and placed in round opaque
containers to become acclimatized to the environment to be used for
data collection. Resting MAP and HR were recorded using a
computer-based data collection system (Maclab; AD Instruments).
Efficacy of SAD was tested by injection of phenylephrine and
nitroprusside as described for study 1. The sympathetic contribution
to MAP was assessed by the acute MAP response to ganglionic
blockade using a bolus injection of hexamethonium (20 mg/kg;
Sigma) and methyl atropine (0.1 mg/kg IV; Sigma). The peak change
in MAP was taken within 2 minutes after administration.7 On a
second day of data collection (separated by $2 days), blood samples
were collected for assay of plasma catecholamines before and after
desipramine (1 mg/kg bolus followed by 30- to 45-minute infusion at
1.6 mg z kg21 z min21; Sigma).

Data Analysis
Study 1
Six values for MAP and HR were acquired every hour with
radiotelemetry. These values were averaged to obtain an hourly
mean, which was used to calculate a daily mean. The 1-hour values
were averaged each day for a daily mean. The SD of this daily mean
was taken as an index of MAP lability. The statistical program
SuperANOVA (Abacus Concepts) was used to generate 3-factor
ANOVA (Intact/SAD3Sham/Wrap3Time) for MAP, HR, MAP
lability, body weight, and fluid intake. Two-factor ANOVA
(Group3Time) was used for pairwise comparisons when a main
effect or interaction reached statistical significance. The acute effects
of Wrap/Sham surgery were assessed by comparing MAP and HR
during a 48-hour control period with values during a 16-hour
post–wrap/sham period (the hours of 7:00 AM to 3:00 PM were not
included in the postmean to allow for surgery and recovery from
anesthesia). From these values, a change in MAP and HR was
calculated for pre-to-post comparison using ANOVA. Significance
was accepted at P,0.05. All data are expressed as mean6SEM.

Study 2
A 30-minute recording of MAP, SD of MAP, and HR was made each
day of data collection. These values were averaged and compared
using 2-factor ANOVA (Intact/SAD3Sham/Wrap). The peak
change in MAP and HR responses within 2 minutes after ganglionic
blockade were compared with preganglionic blockade MAP and HR
using 3-factor ANOVA. Significance was accepted at P,0.05. All
data are expressed as mean6SEM.

Results
The efficacy of SAD was assessed according to several
criteria (shown in the Table). Animals without complete SAD

478

Chronic SAD and Renal Hypertension

Figure 1. MAP and HR are shown during the control period before SAD surgery, the period before renal wrap, and
continuously for 28 days after renal
wrap. MAP was not different between
SAD and intact animals.

Downloaded from http://hyper.ahajournals.org/ by guest on January 5, 2018

during the final test session were removed from the study. For
animals in study 2, a 30-minute estimate of the lability of
arterial pressure was taken during a 3- to 4-hour recording
session. In addition, baroreflexes were tested. Only animals
with increased MAP lability and a deficit in reflex function
were included in study 2. Differences in MAP, HR, and SD of
MAP among groups in study 2 were similar to the differences
seen among groups in study 1.
Study 1
Body weight was not different among groups of animals
during the control period. Growth rates of the rats in each
group were similar as indicated by parallel increases in body
weight through the study; however, animals undergoing SAD
and renal wrap lost more weight after surgery than the
respective sham-operated animals. After surgical recovery
(typically 2 days), all animals were healthy and gaining
weight throughout the study. Fluid intake did not differ
among groups during the control period. However, SAD rats
consistently drank less water over the duration of the study.
Although renal wrapped animals increased their fluid intake
in response to reduced renal function, the fluid intake of the
SAD-Wrap rats remained less than in the Intact-Wrap
animals.
MAP and HR measured throughout the study are shown in
Figure 1. Arterial pressure was not different among groups
during the control or prewrap period (Figure 1A). Threefactor ANOVA indicated that the renal wrap procedure
resulted in an increase in arterial pressure over the 4-week
postwrap period; however, the denervation of the baroreceptors did not affect the course of the hypertension. HR was not
different among groups during the control period (Figure 1B).
Baroreceptor denervated animals had a lower HR. Although
the wrap/sham surgery did not affect HR in SAD rats, there
was a significant decrease in Intact renal wrapped animals.
The magnitude of the changes in arterial pressure after
induction of hypertension were greater in SAD animals.
Renal wrap produced significant increases in arterial pressure
compared with rats that underwent unilateral nephrectomy

alone (561 versus 4663 mm Hg). The rise in MAP during
the first 24 hours after renal wrap surgery was greater in the
SAD animals than in Intact animals (4663 versus
5864 mm Hg). The reason for the exaggerated increase in
MAP after renal wrap in the SAD animals presumably was
the absence of a reflex response to the pressor stimulus
(260615 bpm in Intact animals versus 214615 bpm in
SAD animals).
The lability of MAP throughout the study is shown in
Figure 2. ANOVA revealed a significant increase in the
variability of MAP after baroreceptor denervation. After the
renal wrap procedure in these animals, arterial pressure
lability increased dramatically and then stabilized at a level
that was higher than that of the other groups of rats. Intact
animals subjected to renal wrapping also experienced an
increase in the lability of MAP immediately after wrap, which
then fell to a level that was still significantly elevated. As
shown in the inset of Figure 2, the SD of arterial pressure was
significantly elevated in both hypertensive groups of rats
relative to their respective control animals; however, the
lability of MAP was consistently greater in the SAD rats.
Study 2
The sympathoadrenal contribution to MAP was studied in
Intact and SAD normotensive and hypertensive rats. The
magnitude of the hypertension was similar in Intact and SAD
renal wrapped animals in this study compared with study 1
(Intact-Sham, 12363 mm Hg; Intact-Wrap, 15064 mm Hg;
SAD-Sham, 11669 mm Hg; SAD-Wrap, 15364 mm Hg).
As shown in Figure 3, MAP decreased significantly after
ganglionic blockade. The fall in arterial pressure was greater
in the 2 groups of hypertensive animals (Intact-Wrap,
27364 mm Hg; Intact-Sham, 24962 mm Hg; SAD-Wrap,
29766 mm Hg; SAD-Sham, 27765 mm Hg). In addition,
the fall in arterial pressure was greater in both groups of SAD
animals, resulting in a significantly lower final MAP after
blockade of the autonomic nervous system compared with
Intact rats.
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Figure 2. SD of 1-hour blood pressure values
were used as an index of lability of MAP. Inset,
Weekly average of the lability of MAP after
Wrap or Sham surgery. *P,0.05 vs Sham.
†P,0.05 vs Intact.
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Resting levels of plasma norepinephrine (NE) were significantly higher in the Intact renal wrap animals than in with
sham-operated rats (Figure 4). In contrast, the hypertensive
SAD rats had lower resting plasma NE levels relative to both
normotensive SAD and hypertensive Intact animals. Plasma
epinephrine was not different among the 4 groups of rats.
Animals were challenged with desipramine to block neuronal
uptake of catecholamines to determine whether an enhanced
uptake of NE influenced circulating levels of the biogenic
amines. ANOVA revealed a significant effect of desipramine;
however, plasma NE increased only in the SAD groups and
the Intact hypertensive group of rats, not in the Intact
normotensive animals.

Discussion
This study had 2 principal findings. First, SAD significantly
augmented sympathoadrenal component maintaining arterial
pressure compared with intact rats. This enhanced sympathetic nervous system function was present in both normotensive and hypertensive rats. Second, despite the marked
increase in sympathoadrenal function associated with SAD,
long-term levels of resting arterial pressure were similar in
Intact and SAD animals whether normotensive or
hypertensive.

Figure 3. MAP is shown during a control period before (filled
bars) and after (open bars) ganglionic blockade. Ganglionic
blockade was achieved by bolus intravenous injection of 20 mg
hexamethonium and 0.1 mg atropine. *P,0.05 vs respective
Sham. †P,0.05 vs respective Intact.

SAD results in acute increases in sympathetic activity
causing an increase in MAP. Physiological8 –11 and biochemical12,13 evidence indicates that the hypertension within the
first 1 to 4 days after SAD is produced by sympathetic
hyperactivity. However, the initial level of hypertension after
SAD does not appear to be maintained.10,14 –16 Some studies
have shown that chronic SAD produces moderate increases in
resting MAP relative to Intact animals,12,17–19 whereas others
have reported that arterial pressure is not elevated chronically.10,15,20 In the present study, an elevated MAP was not
observed in chronic SAD animals (5 to 6 weeks after SAD)
through the use of radiotelemetry or recording MAP with
chronic catheters. Many explanations may contribute to
differences in MAP reported in baroreceptor denervated
animals, including recording conditions, time of day, strain of
rat, and degree of stress that the animal may experience.20,21

Figure 4. Plasma NE and epinephrine (Epi) are shown during a
control period before (Pre-Des) and after (Post-Des) neuronal
uptake inhibition with desipramine (1 mg/kg bolus and then 1.6
mg z kg21 z min21 infusion). *P,0.05 vs respective Sham.
†P,0.05 vs respective Intact. Brackets above the pairs of bars
represent significant increases in plasma NE.
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The level of activity of the sympathetic nervous system chronically after SAD also is unclear. Some indexes of sympathetic
activity, such as plasma dopamine b-hydroxylase and NE12 and
ganglionic blockade responses,10 have been shown to be sustained
when MAP return toward normal, whereas other indicators, such as
renal sympathetic activity11 and adrenal catecholamine synthesis,13
are not chronically elevated. In the present study, a persistent
increase in sympathoadrenal activity was observed in sham
wrapped SAD rats. Sympathoadrenal activity was assessed in the
present study using the MAP response to ganglionic blockade and
plasma catecholamine levels at rest and after uptake inhibition with
desipramine. Neural support of MAP was clearly increased in the
SAD rats. Resting NE values were not different between normotensive SAD and intact rats, but there was a significant increase in
plasma NE in the SAD rats after uptake inhibition. Although many
factors at the neuroeffector junction affect overflow of NE into
plasma, a significant increase in plasma NE after desipramine
suggests that neuronal uptake mechanisms in the SAD rats may be
enhanced.
An increase in the sympathoadrenal contribution to arterial
pressure was observed in SAD hypertensive animals relative
to the Intact renal wrapped animals. The MAP response to
ganglionic blockade was greater in the SAD-Wrap animals,
suggesting an increased sympathetic activity. Although resting plasma NE levels were not significantly greater in the
hypertensive SAD rats, plasma NE increased significantly
after NE uptake inhibition in both hypertensive groups of rats.
There is evidence from other studies that uptake of NE
increases with the level of sympathetic nerve activity.22 In the
present study, the 3 groups of rats demonstrating an exaggerated response to ganglionic blockade also experienced a
significant enhancement of plasma NE after desipramine.
These findings suggest that the severe long-term reduction in
baroreflex sensitivity produced by SAD leads to an activation
of the sympathetic nervous system. However, even after the
baroreflex resets to a higher level in renal wrap hypertension,
there does not appear to be alterations in reflex control of
renal nerve activity (S. Mifflin, personal communication).
This suggests that mechanisms besides reduced baroreflex
sensitivity are important in the hypertensive process.
Although SAD resulted in greater levels of sympathetic
function in the hypertensive rats, the resting level of arterial
pressure was not different compared with Intact animals. The
absence of reflex bradycardia and sympathoinhibition after
renal wrap in SAD animals resulted in a greater initial rise in
MAP. However, this augmented hypertension was not sustained for .24 hours despite the greater sympathoadrenal
activation. A similar observation has been made in SAD dogs
in which anephric animals were challenged with a volume
infusion.23 In these animals, arterial pressure rose to a higher
level than was observed in intact animals, but within 24
hours, the arterial pressure was similar in both groups of dogs.
Although other studies have shown that SAD animals may
develop a more rapid rise in MAP when renal hypertension in
induced,24,25 only 1 study has demonstrated an exaggerated
and sustained MAP after renal hypertension in SAD
animals.26
The reason for the equivalent levels of MAP between SAD
and Intact animals was not examined in the present study. Based

on work by others, a pressure natriuresis and diuresis may be
responsible for reducing extracellular fluid and blood volumes
after baroreceptor deafferentation. As Hall et al27 have shown,
pressure natriuresis serves to limit the degree of hypertension.
Support for this has also been shown in baboons. When renal
arterial pressure is servo-controlled to maintain normotensive
renal perfusion after SAD, the increase in peripheral arterial
pressure is enhanced.28 In contrast, Osborn and England15 were
not able to show that pressure natriuresis contributed to the
normalization of MAP after SAD in the rat. In that study, resting
MAP returned to normal levels after SAD even though .50% of
the daily water intake was administered by intravenous infusion.
Reduced water intake after SAD has also been suggested to
contribute to reductions in MAP by reducing body fluid volume.29 In the present study, 2 observations suggest that both
normotensive and hypertensive SAD animals may have reduced
extracellular fluid and blood volumes. First, water intake decreased after SAD and remained suppressed. Second, after
ganglionic blockade, the minimum arterial pressure was significantly lower in SAD rats at a time before other compensatory
mechanisms such as renin release would likely be activated.
Collectively, we hypothesize that pressure natriuresis and diuresis reduce pressure despite sympathetic hyperactivity.
In conclusion, sinoaortic denervation produces persistent activation of the sympathetic nervous system. In both normotensive and hypertensive groups, augmented depressor responses to
ganglionic blockade and increased plasma NE levels after
uptake inhibition were observed in SAD animals. However, the
enhanced sympathetic activation did not alter resting levels of
MAP in either normotensive or hypertensive animals. These
results indicate that alterations in baroreflex sensitivity may
cause alterations in sympathetic activity, but other compensatory
mechanisms may preclude a sustained influence on MAP.
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